跳至主要内容
临床试验/CTRI/2018/06/014584
CTRI/2018/06/014584已完成未知

Clinical efficacy of intralesional platelet rich plasma therapy in melasma - PRP therapy

Department of Dermatology0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with clinical diagnosis of melasma

排除标准

  • 1. Patients with known platelet dysfunction syndrome, critical thrombocytopenia ( <50,000/ul), any hemodynamic instability or with hemoglobin level < 10 g/dl.
  • 2. Patients with local inflammatory skin disorders or active herpes infection at the site of the procedure.
  • 3. Patients with corticosteroid injection at treatment site within 1 month or systemic use of corticosteroids within 2 weeks.
  • 4. Patients diagnosed with cancer especially hematopoietic or of bone.
  • 5. Patient with known hypersensitivity to platelet rich plasma or any other form of blood components.
  • 6. Patients with any other facial dermatoses.
  • 7. Patients on anticoagulants, oral contraceptive pills, hormone replacement therapy, NSAIDs, antiepileptic medications, isotretinoin or any other phototoxic medication.
  • 8. Pregnancy and lactation.

研究者

相似试验